
0:00
32:14
Drug interactions in infectious diseases encompass complex pharmacokinetic and pharmacodynamic mechanisms that significantly impact patient safety and therapeutic outcomes. These events commonly arise from alterations in drug absorption, plasma protein binding, hepatic and intestinal metabolism, and renal excretion. Preclinical models and in vitro testing methods—such as human microsomes, recombinant enzymes, and hepatocyte cultures—help predict how compounds interact before human clinical trials. However, challenges remain in scaling laboratory data to clinical settings due to genetic polymorphisms and interindividual variability. Ultimately, understanding these metabolic pathways allows healthcare professionals to optimize anti-infective regimens while minimizing adverse effects and therapeutic failures.
You can listen and download our episodes for free on more than 10 different platforms:
https://linktr.ee/pharmacy_simple
Produced by:
https://www.podcaistudio.com/
You can listen and download our episodes for free on more than 10 different platforms:
https://linktr.ee/pharmacy_simple
Produced by:
https://www.podcaistudio.com/
Weitere Episoden von „Pharmacy Made Simple“



Verpasse keine Episode von “Pharmacy Made Simple” und abonniere ihn in der kostenlosen GetPodcast App.








